Mike Erdman retweeted
What causes acute kidney injury?
Well, the list is long.... but IV contrast is not one of them.
We reviewed 13 studies (9 retrospective, 4 prospective), which included 25,950 patients. Based on currently available data, CA-AKI is not a thing.
Check out our review for more details.
jem-journal.com/article/S073…
@long_brit
@MGottliebMD
#emergency #emergencymedicine #criticalcare #icu #erlife #iculife #science #data #research #army #armymedicine #armyemdoc #resuscitation #kidney #nephrology #bean #medx #medtwitter
Mike Erdman retweeted
Tons of NEW DATA about andexanet, presented as part of FDA hearing last week. If you couldn’t make it through the short 6h meeting, GOOD NEWS, I’ve watched it and highlighted the important points.
A🧵
Mike Erdman retweeted
You may have heard that AA is "less expensive" than 4PCC for reversal when you take into account the "entire cost of the hospitalization bc the outcomes are better"
This slide (from AZ) shows that "data". It's from a 2020 ASHP Poster.
1/2
Mike Erdman retweeted
A summary of "Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage" (ANNEXA-I) by Stuart Connolly et al NEJM:
1. 🔬 Study Purpose: Evaluated the effectiveness of andexanet alfa in controlling hematoma expansion in patients with intracerebral hemorrhage on factor Xa inhibitors.
2. 🧪 Methods: 530 patients were randomly assigned to receive either andexanet or usual care, with primary endpoints being hemostatic efficacy and safety endpoints like thrombotic events and death.
3. 📊 Results: Andexanet achieved better control of hematoma expansion (67.0%) compared to usual care (53.1%), but it increased thrombotic events (10.3% vs. 5.6%).
4. 💉 Treatment Efficacy: The median reduction in anti–factor Xa activity was significantly higher with andexanet (94.5%) compared to usual care (26.9%).
5. ⚠️ Safety Concerns: While effective in controlling hematoma expansion, andexanet was associated with a higher risk of thrombotic events, including ischemic stroke.
#CODE #ICH
nejm.org/doi/full/10.1056/NE…
Mike Erdman retweeted
Is anaerobic coverage necessary for aspiration pneumonia with metronidazole or Augmentin?
NEJM JWatch reports from a large retro study with N ~ 4000
Findings show no added mortality benefit but an increased risk of CDI
journal.chestnet.org/article…
#IDTwitter #IDXposts
Mike Erdman retweeted
Things We Do for No Reason™: Furosemide‐albumin coadministration for diuretic resistance - Vipler - Journal of Hospital Medicine - Wiley Online Library shmpublications.onlinelibrar…
Mike Erdman retweeted
Consensus Statement Advocates for Immediate Change to Intracerebral Hemorrhage Protocols
#CodeICH
neurologylive.com/view/conse… via @neurology_live
Mike Erdman retweeted
#STROKE Special Report by Li and Yakhkind et al.: "Code ICH: A Call to Action" — an emergency pathway for ICH patients that facilitates rapid delivery of bundled treatments. #AHAJournals ahajournals.org/doi/10.1161/…
Mike Erdman retweeted
📻 Looking for a pharmacy residency program in 🌞Florida🌴 @ a large academic medical center? 💊
✔️ all the boxes @ UF Health Jacksonville 🐊
#ashp #pharmacy
Visit our website to find detailed information on the application process: ufhealthjax.org/pharmacy-res…
Mike Erdman retweeted
Announcement🥳:
🐊💊PGY-2 Infectious Diseases 🦠🔬 will be going to the ASHP match. Limited spots during PPS, so book your PPS ASAP. 🛬
Not making it to Midyear, set-up a virtual visit, contact us here to start the virtual process! 💻ufhealthjax.org/pharmacy-res… #TwitterX #IDTwitter
Mike Erdman retweeted
Join us next Tuesday, Oct. 10 on X for a discussion about the @NeurocritCareJ article "Safety & Efficacy of Ketamine Without Intubation in the Management of Refractory Seizures." Questions begin at 9 a.m. CT & will be posted hourly. Read the article now: ow.ly/Quz350PSGlR
Mike Erdman retweeted
In honor of Pride Month, the Acosta Bridge will be lit through Sunday, June 11 in Downtown Jacksonville.
Mike Erdman retweeted
ANEXA-I is stopping early for… “achieving pre-specified stopping criteria of superior haemostatic efficacy, the ability to limit the expansion of a potentially life-threatening bleed in the brain, versus usual care”. 🤔
astrazeneca.com/media-centre…
Mike Erdman retweeted
🚨🚨🚨 New ID PharmD Job 🚨🚨🚨
UF Health Jacksonville is hiring an additional ID Pharmacist to assist in their 695 bed system in NE Florida. #IDtwitter #sidp #accp
If you have any questions/interest, feel free to DM.
See job posting below. ☀️🌴🏖️
careers.shands.ufl.edu/psc/u……
Mike Erdman retweeted
Burst Suppression as a primary target for Refractory Status Epilepticus — is Over
#curingcoma
n.neurology.org/content/100/…
Mike Erdman retweeted
Texas heard SB888 yesterday, an anti-trans bill targeting doctors caring for trans youth.
After one person spoke, the chair then read off the names of 3 people to speak next...
And just...
Watch...
God I love Gen Z💀
Mike Erdman retweeted
Doctors at a major US insurance company deny tens of thousands of claims a month without even looking at patients’ files.
“We literally click & submit,” a former Cigna doctor told @ProPublica & @Capitol_Forum. “It takes all of 10 seconds to do 50 at a time.”
The inside story 🧵
Mike Erdman retweeted
For those too young to have lived through what happened twenty years ago, a thread of self-styled left/liberal types endorsing the invasion of Iraq
